newsfilter
← Latest News
GlobeNewswire·

Revolution Medicines to Report Financial Results for Third Quarter 2026 After Market Close on November 4, 2026

REDWOOD CITY, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (NASDAQ:RVMD), a global, commercial-stage oncology company dedicated to discovering, developing and delivering innovative medicines